How Long Does Seroquel 25 mg Stay in Your System?

Quetiapine, the active ingredient in Seroquel, has an elimination half-life of roughly six to seven hours, which means a single 25 mg dose is mostly cleared from your bloodstream within about a day and a half. That straightforward number hides quite a bit of variation, though, because liver enzymes, other medications, and even the formulation you take can stretch or shrink that window. Detection in drug testing adds another layer of complexity, since the drug itself nearly vanishes from urine while its metabolites linger and can trigger unexpected false positives.

How Quickly a 25 mg Dose Reaches Its Peak

After you swallow a 25 mg immediate-release (IR) tablet, quetiapine is absorbed rapidly. Pharmacokinetic studies report that the median time to reach peak plasma concentration is one to two hours.¹ That is fast compared with many psychiatric medications, which is part of why Seroquel at low doses is so commonly prescribed off-label for insomnia: the sedation kicks in quickly, peaks early, and then fades as the drug is cleared.

If you are taking the extended-release (XR) version instead, the timeline shifts. In a head-to-head comparison of the two formulations, the IR tablet hit its peak at about two hours while the XR tablet reached its peak at about five hours.² The XR version is designed to slow the release of drug into your gut, spreading out the absorption curve. In a crossover study comparing both formulations, the IR group hit peak concentration at a median of two hours and the XR group at five hours, with the XR peak concentration being meaningfully lower.³ This matters for how quickly the drug kicks in, though as we will see, both formulations end up delivering roughly the same total amount of drug to your system over 24 hours.

How Your Body Breaks Down Quetiapine

Quetiapine is processed almost entirely by your liver. The enzyme primarily responsible is CYP3A4, one of the most active drug-metabolizing enzymes in the body.⁴ A second enzyme, CYP2D6, handles some of the secondary metabolic pathways, and a related enzyme, CYP3A5, also contributes.⁵ The liver converts quetiapine into a range of metabolites, some of which are pharmacologically active. One of those, norquetiapine (N-desalkylquetiapine), has its own receptor activity and its own half-life, so even after the parent drug has dropped to undetectable levels in blood, metabolites are still circulating and being cleared.

What is striking about quetiapine’s metabolism is how thorough it is. Less than one percent of the drug is excreted unchanged in urine.⁵ That near-total hepatic processing means a standard urine drug screen often cannot detect quetiapine directly, which has practical consequences for anyone facing a drug test.

What Makes Quetiapine Leave Your System Faster or Slower

Because CYP3A4 does almost all the heavy lifting, anything that speeds up or slows down that enzyme changes how long quetiapine stays in your body. The effects are not subtle. In clinical studies, ketoconazole, a strong CYP3A4 inhibitor, increased quetiapine’s peak blood levels by about 3.4-fold and slashed the drug’s clearance by roughly 84%.⁶ That means if you are taking a strong CYP3A4 inhibitor alongside your Seroquel, the drug hangs around much longer and reaches much higher levels. Ketoconazole is the classic research example, but other strong CYP3A4 inhibitors, such as certain antifungals and HIV protease inhibitors, can produce similar effects.

The reverse happens with CYP3A4 inducers. Carbamazepine, an anticonvulsant that revs up CYP3A4 production, dropped quetiapine’s peak levels by about 80% and increased the body’s clearance of the drug by roughly 7.5-fold in the same set of studies.⁶ With clearance that much faster, quetiapine barely reaches therapeutic levels, and it leaves the system far sooner than the standard half-life would predict. Other common CYP3A4 inducers, like phenytoin and rifampin, have the potential to do similar things. This is one reason psychiatrists ask about your full medication list before prescribing quetiapine.

Liver Disease

Because the liver does essentially all of the work, liver disease can slow things down. A study of patients with alcoholic cirrhosis found enough inter-subject variability in quetiapine clearance to warrant caution when escalating doses, even though the recommended starting dose of 25 mg did not need to change.⁷ In practical terms, if your liver is compromised, a 25 mg dose can linger longer and reach higher levels than it would in someone with normal liver function. The degree of that effect varies a lot from person to person, which makes it hard to predict exactly how much longer the drug stays around.

Genetic Variation

People carry different versions of the CYP3A4 gene, and those variations affect how efficiently the enzyme works. Modeling work has shown that CYP3A4 polymorphisms alter quetiapine pharmacokinetics, meaning that two healthy people of the same age and weight can clear the drug at different rates simply because of genetic differences in their liver enzymes.⁸ Age and body size also play roles, but enzyme genetics are probably the biggest source of person-to-person variation that remains invisible unless you go looking for it.

Immediate-Release vs Extended-Release and What It Means for Duration

If you are specifically asking about a 25 mg dose, you are almost certainly taking the immediate-release tablet, since the XR version is typically started at 50 mg and titrated upward. Still, the distinction matters because the two formulations behave differently in the first few hours even though they deliver the same overall drug exposure.

A review of the pharmacokinetic differences found that the XR tablet delays the time to peak plasma concentration by two to four hours and lowers the peak concentration by about 13% compared with the IR tablet, while the total amount of drug absorbed and the overall half-life remain similar between the two.⁹ Direct comparison data confirmed this: the 24-hour area under the curve for the XR formulation was about 1.04 times that of the IR formulation, well within the range considered bioequivalent.² So the XR version does not really stay in your system longer in a meaningful sense; it just enters more slowly and peaks more gently. The total time until the drug is fully cleared is roughly the same for both.

Drug Testing and Detection Windows

People often want to know how long Seroquel stays in their system because they are facing a drug test, and this is where things get counterintuitive. Standard urine drug screens are designed to catch classes of drugs like opioids, benzodiazepines, and amphetamines. Quetiapine is not in any of those categories, so a routine panel will not flag it. But quetiapine creates two problems in drug testing: it is hard to confirm when you want to find it, and it sometimes triggers false positives for things you did not take.

On the first point, because less than one percent of quetiapine is excreted unchanged in urine, routine toxicological screening often returns false negative results when someone actually has taken the drug. Researchers have identified that the metabolite N-desalkylquetiapine can serve as a reliable marker of quetiapine use in urine when tested with gas chromatography-mass spectrometry.⁵ The metabolite sticks around longer than the parent drug and is present in higher concentrations in urine, making it a more practical target. But most standard lab panels are not looking for it specifically.

On the second point, quetiapine has been reported to trigger false positive results on urine immunoassay screens for ketamine. In documented cases, patients taking quetiapine tested positive for ketamine on the initial immunoassay, but the result turned out to be false when confirmatory testing was performed.¹⁰ If you are on quetiapine and a urine screen comes back positive for something you did not take, mention the medication to whoever ordered the test. Confirmatory methods like gas chromatography-mass spectrometry can sort out the real answer.

Blood Testing

For therapeutic drug monitoring, quetiapine levels are typically measured in serum or whole blood. A study of therapeutic drug-monitoring specimens found a consistent blood-to-serum ratio of about 0.74, meaning whole-blood concentrations run about 25% lower than serum concentrations for the same sample.¹¹ This is a stable, predictable relationship, which means labs can reliably convert between the two measurements. In blood, quetiapine is generally detectable for one to two days after a single dose at most, depending on the dose and your metabolism. At 25 mg, the concentrations are quite low to begin with, so the blood detection window is on the shorter end.

Hair Testing

Hair testing extends the detection window dramatically. In animal research, quetiapine and its metabolite 7-hydroxyquetiapine could still be detected in hair roots 28 days after a single dose, long after blood levels had dropped to zero.¹² Hair root analysis is not part of standard employment or clinical drug testing, but it is used in forensic contexts and can potentially reveal quetiapine use weeks to months after the last dose. For a single 25 mg dose, the concentrations incorporated into hair would be quite low, and whether they are practically detectable in human hair testing depends on the sensitivity of the laboratory’s method.

Why You Can Feel Sedated Longer Than the Drug Lasts

One of the more frustrating aspects of low-dose Seroquel is waking up groggy even though the drug’s half-life suggests it should be mostly gone. At 25 mg, the dominant pharmacological effect is antihistamine sedation rather than antipsychotic dopamine blockade. Quetiapine binds strongly to histamine H1 receptors, and a positron emission tomography study in healthy volunteers found that the degree of H1 receptor occupancy in the brain correlated with how sleepy people felt, independent of their plasma drug levels.¹³

This finding helps explain the disconnect. The drug may leave your blood on schedule, but its effect on histamine receptors in the brain can persist somewhat beyond what plasma levels alone would predict. At a 25 mg dose, you are getting enough histamine blockade to cause real drowsiness, but you are far below the doses used for psychotic disorders. The practical takeaway is that next-day grogginess from a bedtime 25 mg dose is common, and it does not necessarily mean the drug is still circulating at meaningful levels. Your brain’s histamine system just takes some time to fully reset.

The Timeline at a Glance for a Single 25 mg IR Dose

Putting the pharmacokinetic data together for a person with normal liver function, no interacting medications, and average CYP3A4 activity, a single 25 mg immediate-release dose follows a rough timeline:

Peak blood level: reached in about one to two hours after swallowing the tablet.
Half-life: approximately six to seven hours, meaning that about half the drug is cleared every six to seven hours.
Near-complete clearance from blood: after roughly five half-lives (about 30 to 35 hours), quetiapine concentrations in blood fall below detectable thresholds for most assays.
Urine metabolites: may be detectable for two to three days, though standard drug screens often miss them entirely.
Hair: theoretically detectable for weeks, though this is not standard testing.

Those numbers shift meaningfully in either direction depending on your liver health, your other medications, and your genetics. A strong CYP3A4 inhibitor can turn a day-and-a-half clearance window into something closer to a week’s worth of elevated exposure, while a strong inducer can push the drug through your system so quickly that it barely registers.

Why 25 mg Gets Special Attention

The 25 mg dose occupies an unusual place in quetiapine prescribing. It is the recommended starting dose for approved indications like schizophrenia and bipolar disorder, where patients are expected to titrate upward quickly. But it is also one of the most widely prescribed doses on its own, used off-label for insomnia and anxiety. At this dose, the pharmacokinetic questions are slightly different from those at higher doses. Blood levels peak lower and clear sooner, which means the detection window in blood and urine is shorter than for someone taking 300 or 800 mg daily.

The study of hepatic impairment specifically used 25 mg as its test dose and found that the starting dose did not need adjustment even in patients with cirrhosis, though dose escalation beyond that warranted caution.⁷ This makes 25 mg something of a pharmacokinetic baseline: if your system handles this dose normally, the half-life and clearance values described above apply fairly directly. The more you deviate from normal liver function or the more interacting drugs you add, the less predictable those numbers become.

For most people taking a single 25 mg tablet at bedtime, the drug will be functionally out of the bloodstream by late the next afternoon. Whether you still feel its effects at that point is a separate question, and one that depends more on your brain’s sensitivity to histamine blockade than on what a blood test would show.